Igor Pivovarov

Moscow Russian Federation

CEO

Medical / Health Care / Pharmaceuticals

Co-Founder, CEO of HemaCore, Member of Board of several companies. 14 years business experience - CTO, CMO, CEO. 7 years innovation projects experience. Raised ~$22M investments. HemaCore - biotech company, develops new medical devices and methods for hematology. Company was invested by RUSNANO to bring to the market “Thrombodynamics” – new global assay for monitoring and prognosis of blood clotting disorders: bleeding and thrombosis (precursors of heart attacks and strokes)